ArticleArchives of microbiology2026
Toward sustainable production of bulnesol and elemol enabled by synthetic biology in Saccharomyces cerevisiae.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Guaiac oil obtained from the heartwood of the Bulnesia sarmentoi tree native to South America is prized for its characteristic woody-rosy aroma. The aroma is primarily attributed to bulnesol, which makes up ~ 40% of the oil. B. sarmentoi is classified as an endangered species by the International Union for Conservation of Nature (IUCN) Red List, its sensitivity to climate change and challenges associated with its cultivation hinder the production of guaiac oil. We had previously characterized a unique sesquiterpene synthase (StBUS/ELS) from potato that produced a mixture of bulnesol and elemol when incubated with farnesyl pyrophosphate. It was shown that elemol was a thermal rearrangement product of bulnesol. The present study sought to engineer yeast, Saccharomyces cerevisiae, for the sustainable production of bulnesol using StBUS/ELS. Yeast expressing StBUS/ELS was found to produce a mixture of elemol, γ-eudesmol, α-eudesmol, β-eudesmol and bulnesol with pH of the fermentation medium having a significant influence on the product profile. A pH of 7.5 favored the production of bulnesol/elemol, whereas an acidic pH (2.5 − 5.5) formed eudesmols. Further metabolic engineering for enhanced precursor and co-factor supply while also eliminating the need for galactose inducers resulted in a 1.85-fold improvement in bulnesol/elemol titers. Finally, fed-batch fermentation with the best engineered strain resulted in a combined bulnesol/elemol titer of 103.92 ± 7.41 mg/L, while total sesquiterpene titers exceeded 460 mg/L. This study, for the first time, demonstrates the influence of pH on the product profile of a terpene synthase in vivo and provides a foundation toward the sustainable production of bulnesol in microbial host platforms.
Indexed as
Identifiers
41989556What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.